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Research Article 
ABSTRACT  In order to combat the on-going malaria epidemic, discovery of 
new drug targets remains vital. Proteins that are essential to survival and spe-
cific to malaria parasites are key candidates. To survive within host cells, the 
parasites need to acquire nutrients and dispose of waste products across mul-
tiple membranes. Additionally, like all eukaryotes, they must redistribute ions 
and organic molecules between their various internal membrane bound com-
partments. Membrane transport proteins mediate all of these processes and 
are considered important mediators of drug resistance as well as drug targets 
in their own right. Recently, using advanced experimental genetic approaches 
and streamlined life cycle profiling, we generated a large collection of Plas-
modium berghei gene deletion mutants and assigned essential gene func-
tions, highlighting potential targets for prophylactic, therapeutic, and trans-
mission-blocking anti-malarial drugs. Here, we present a comprehensive 
orthology assignment of all Plasmodium falciparum putative membrane 
transport proteins and provide a detailed overview of the associated essential 
gene functions obtained through experimental genetics studies in human and 
murine model parasites. Furthermore, we discuss the phylogeny of selected 
potential drug targets identified in our functional screen. We extensively dis-
cuss the results in the context of the functional assignments obtained using 
gene targeting available to date. 
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INTRODUCTION 
The malaria parasite has adopted a highly complex life cy-
cle involving a continuous switching between vertebrate 
hosts and anopheline mosquitoes. Within humans, Plas-
modium species are obligate intracellular parasites moving 
through three different life-cycle stages. After an infectious 
mosquito bite, a single phase of preclinical growth within 
the host liver cells commences [1]. Next, fast proliferating 
blood-stage parasites are the cause of malaria-associated 
pathology and severe disease outcome [2]. Finally, some of 
the asexual blood-stage parasites are triggered to develop 
into male or female gametocytes, which are required for 
sexual reproduction following a mosquito blood meal [3,4]. 
Despite a gradual decline in annual malaria cases and 
deaths, the parasite remains one of the largest global kill-
ers. In 2015, WHO reported 150-300 million cases and 
438,000 deaths [5]. Difficulty in combating the disease is 
exacerbated by the growing resistance to anti-malarial 
drugs and the absence of an effective vaccine. The contin-
uous need for new therapeutic anti-malarial drugs is un-
questioned. Yet, due to limited availability, there is a much 
more pressing need for drugs that can prevent infections 
by acting prophylactically on the liver stage of the parasite, 
and transmission-blocking compounds, which kill the ga-
metocytes thus helping to prevent the spread of the dis-
ease. Chemoprophylaxis is not only important for travellers 
[6] but also particularly for women in endemic areas in 
their first or second pregnancy [7]. Thus, there is a critical 
need for novel drugs that may be used prophylactically, 
therapeutically, or to block transmission [8]. 
As defined by the Medicines for Malaria Venture in 
there 2015 annual report [9], ideal medicines for treatment 
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and protection would both be suitable for mass drug ad-
ministration programs and require a single encounter 
treatment, or better still a single exposure treatment, to 
help improve compliance. Treatment of infection should be 
effective against all life-cycle stages of all five malaria spe-
cies infecting humans, including resistant strains, and re-
sistance against the new drug should be difficult to achieve.  
Generally, it is believed that these features may be best 
obtained by the combination of at least two active com-
pounds, one fast acting for immediate clearance of the 
infection and a second, slower-acting compound providing 
long duration of efficacy. Furthermore, an ideal treatment 
would be gametocytocidal to prevent the spread of infec-
tion to mosquitoes, while sporontocidal or liver-stage ac-
tivity would provide a prophylactic component. To com-
plete the wish list of the ideal anti-malarial drug, it should 
also be active against the so-called hypnozoites, the 
dormant stages of certain malaria parasite species (most 
notably P. vivax) that are the cause of relapse infection 
even many years after the infectious mosquito bite. It is 
obvious that the development of the ideal anti-malarial 
drug will not be straightforward and will result in a com-
promise between the long list of desirable attributes and 
features. In this light, it is particularly important that on-
going functional studies of malaria parasite biology contin-
ue to highlight potential new drug targets that have im-
portant roles in the different life-cycle stages of the para-
site and are conserved among all malaria parasite species 
but are absent from or have diverged significantly in hu-
mans, such that compounds acting on these important 
Plasmodium proteins may do so effectively as well as selec-
tively. 
Plasmodium membrane transport proteins (MTP), such 
as the chloroquine resistance transporter (CRT) and the 
ATP-binding cassette (ABC) transporter family, including 
the multidrug resistance proteins (MDR) and the multidrug 
resistance-associated proteins (MRP), are well known for 
their roles in anti-malarial drug resistance [10,11]. MTPs 
are also generally considered potential drug targets in their 
own right [12,13]. Spiroindolones and dihydroisoquin-
olones are new classes of potent anti-malarial drugs, cur-
rently under clinical testing, that have both been shown to 
act via the Plasmodium falciparum cation ATPase, ATP4, 
causing severe disturbance of Na
+
 homeostasis in the para-
site [14-17]. 
To survive and thrive, malaria parasites utilize a range 
of transport processes to import nutrients, export waste, 
and redistribute ions and small organic molecules between 
different sites and organelles [12,18]. MTPs of different 
classes facilitate these processes. Following the functional 
and phylogenetic classification of MTPs from the Trans-
porter Classification Database (http://www.tcdb.org) [19], 
Plasmodium MTPs can be classified as: α-type channels and 
β-barrel porins (TCDB Class 1.A/B); P-P-bond hydrolysis-
driven transporters, here referred to as pumps (TCDB Class 
3.A); porters, including uniporters, symporters, and anti-
porters (TCDB Class 2.A); and unclassified, putative MTPs. 
Experimental genetics is a powerful means to further 
explore critical functions of Plasmodium MTPs for parasite 
survival throughout its complex life cycle [20,21]. Due to 
more efficient experimental and computational methods 
and access to the entire in vivo life cycle, the majority of 
such studies have been performed using murine malaria 
model species, notably Plasmodium berghei, and have fo-
cussed on single MTPs (Table S1). Two of our most recent 
studies have more than doubled the number of targeted 
genes, and have generated loss-of-function mutants in 
both P. falciparum and P. berghei [22,23]. A systematic 
study of the MDR family demonstrated that four of seven 
members fulfil essential functions during blood-stage de-
velopment, highlighting these as potential drug targets [22]. 
While targeting 35 orphan MTPs, Kenthirapalan et al. pro-
duced the largest collection of P. berghei knock-out para-
sites available to date [23]. The 29 available mutant lines 
provide a powerful resource for further studies of malaria 
parasite transport processes. In addition to highlighting six 
genes essential for blood-stage survival including five 
pumps, they also revealed potential prophylactic (MFS6) 
and transmission-blocking (ZIP1) drug targets [23]. 
Here, we performed comprehensive orthology profiling 
by reciprocal Blast of all identified 139 Plasmodium MTPs 
(consisting of the list published by Martin et al. [24] ex-
panded with newly identified candidates) against a selec-
tion of 41 species from the entire breadth of the eukaryotic 
kingdom. To further validate the potential of the eight 
newly identified drug targets, we have explored their phy-
logenetic relationships in detail. These results are dis-
cussed extensively in the context of available insights from 
functional genetics studies of malaria parasite MTPs. 
 
RESULTS AND DISCUSSION 
Comprehensive orthology assignments of Plasmodium 
MTPs 
To identify the levels of conservation of the 139 P. falcipa-
rum MTPs (Table S1) within the eukaryotic domain, we first 
performed an extensive orthology assignment using Blast 
against a set of 41 species (Table S2). We selected a subset 
of species to represent the enormous diversity in the eu-
karyotic domain by including sequences from all kingdoms, 
with an emphasis on protozoan species, commonly used 
model species, and parasite species of great medical or 
veterinary importance. These include the clinically second 
most important human malaria parasite Plasmodium vivax 
and the murine malaria model parasite P. berghei. Plasmo-
dium species belong to a large monophyletic group of 
largely obligate intracellular parasites, the Apicomplexa. 
We included six additional apicomplexan parasites in our 
analysis: two piroplasms (Babesia bovis and Theileria annu-
lata) that cause cattle fever and like Plasmodium species 
belong to the Aconoidasida, and four Conoidasida, includ-
ing parasites of medical (Toxoplasma gondii and Cryptos-
poridium parvum) and veterinary (Neospora caninum and 
Eimeria tenella) importance. 
Apicomplexan parasites are characterized by a complex 
at the apical end that is used to penetrate and enter a wide 
variety of host cells. However, this is not the only peculiar 
subcellular structure of these eukaryotic single cell para-
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sites. Being eukaryotes, one would naturally expect most 
of the commonly shared organelles to be present, but 
while most do retain a single and thoroughly reduced mi-
tochondrion, some have only vague remnants of the cell’s 
power house in the form of mitosomes [25]. An additional 
organelle of endosymbiotic heritage present in the majori-
ty of apicomplexan parasites (though it has been lost in 
Cryptosporidium species) is the former-photosynthetic 
apicoplast [26]. This plastid is of red algal origin, a trait 
shared across a variety of highly divergent species, includ-
ing other alveolates, such as Chromerida and dinoflagel-
lates, but not ciliates. For our analysis, we included four 
alveolates, including two ciliates and one of the closest 
relatives of the Apicomplexa, Vitrella brassicaformis. 
The true evolutionary relationships between highly di-
verse protozoan lineages are unresolved and still a matter 
of dispute but many interesting parallels can be observed. 
Thus Cryptomonads, Haptophyta, and a significant propor-
tion of Stramenopiles, all harbour plastids of red algal 
origin, although at present it is not clear whether these 
plastids originate from single or multiple secondary endo-
symobiotic events [27-29]. In our analysis, we included one 
cryptomonad, Guillardia theta, as well as four strameno-
piles including the oomycete Phytophthora infestans. The 
latter is a plant parasite causing potato blight, which does 
not harbour a plastid, but it does share another interesting 
feature with malaria parasites. Both oomycetes and malar-
ia parasites extensively remodel the host they infect by 
exporting a large repertoire of effector proteins using 
comparable strategies [30]. Further protist representative 
sequences were taken from two Rhizaria, six Excavata, 
including three kinetoplastid parasites, and two Amoebo-
zoa. 
From the plant kingdom, we took a green and a red al-
ga and the most commonly used model plant Arabidopsis 
thaliana. Ophistokonts were represented by two fungi 
(baker’s yeast and the pathogenic Cryptococcus neofor-
mans) and by nine animals, including the parasitic flat-
worm Schistosoma haematobium, the malaria mosquito 
Anopheles gambiae, a number of widely used model or-
ganisms, and of course mouse and human. 
 
Potential prophylactic drug targets 
In our recent functional screen of orphan MTPs, we identi-
fied a critical role for a major facilitator superfamily mem-
ber, MFS6, during liver-stage development, in addition to 
important functions in the blood [23]. Though we identi-
fied a putative orthologue in V. brassicaformis (Figure 1), 
MFS6 is largely Plasmodium-specific and appears absent 
from humans. Its important functions during both liver- 
and blood-stage development justify further exploration of 
the protein as a target for compounds with combined 
prophylactic and therapeutic activity. P. berghei MRP2-
deficient parasites demonstrate a complete arrest in the 
liver, a phenotype that was also observed in P. falciparum 
counterpart MRPs [31]. Like MFS6, MRP2 appears to be 
largely Plasmodium-specific (Figure 1) providing another 
promising drug target. However, for these two MTPs both 
their function and their respective substrates remain unre-
solved. 
Evidence is mounting that transport processes of metal 
ions, in particular of heavy metals such as iron, copper, and 
zinc, could provide efficient targets for chemoprophylactic 
treatments. Although the exact mechanisms are unclear, P. 
berghei liver-stage development is influenced by host iron 
homeostasis [32,33]. Recently, a vacuolar iron transporter 
was described that plays an important (although not criti-
cal) role during liver infection in vivo and in vitro [34]. Para-
sites lacking an alternative zinc–iron permease (ZIPCO) are 
severely affected in liver-stage development in vitro and 
show a delay in prepatency of two days [35]. A similar de-
lay in prepatency was observed following needle injection 
of ctr2
–
 sporozoites despite developing normally in culture 
[23]. Interestingly, these parasites were most severely af-
fected during natural transmission by infectious mosquito 
bites or following subcutaneous injection of the sporozo-
ites. Parasites deficient in the copper channel 1 gene 
(CTR1) completely failed to transmit, but this was at least 
in part attributable to a much reduced and delayed sporo-
zoite production, and the infectivity of these sporozoites 
remains to be determined in more detail to establish 
whether CTR1 like CTR2 plays an important role in the liver 
[23]. Despite the fact that the putative heavy metal trans-
porting MTPs with a demonstrated important role during 
the establishment of new infection are not strictly essential, 
they may still prove interesting targets for prophylactic 
interventions, since none of the MTPs discussed above 
appear to have a clear reciprocal orthologue in humans 
and show only partial sequence matches (Figure 1). 
 
Potential transmission-blocking drug targets 
The importance of heavy metal homeostasis appears not 
to be restricted to mosquito-to-mouse/human transition. 
Also sexual blood-stage parasites, parasite fertility, and 
effective colonization of the mosquito midgut appear to be 
strongly dependent on the correct distribution of these 
cations. 
Where the two copper channels may act in copper 
transport in the liver stages, a copper-transporting P-type 
ATPase (CuTP) was shown to be central to fertility of both 
male and female gametes [36]. Activation of cutp
–
 male 
microgametes, a process known as exflagellation, is re-
duced to ~10% of wild-type and this reduction could be 
phenocopied using an intracellular copper chelator. Cross-
fertilization studies and an even more pronounced reduc-
tion in oocyst numbers indicate additional important roles 
in the female gametes. ZIP1, a paralogue of the liver stage-
specific ZIPCO, is crucial for mosquito colonization [23]. 
Exflagellation in zip1
–
 parasites is reduced to naught, which 
is directly attributable to a nearly complete absence of 
male gametocyte formation. Since ZIP1-deficient parasites 
also have a slightly reduced blood-stage multiplication rate, 
ZIP1 is potentially a very attractive transmission-blocking 
drug target. Indeed, if a compound would be able to target 
ZIPCO and ZIP1, this would be a triple-acting drug that 
could be used prophylactically, therapeutically, and to 
block  spread  of the  disease.  One  disadvantage  could  be  
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FIGURE 1: Orthologies of 
membrane transport pro-
teins of the malaria para-
site. Extensive amino acid 
based reciprocal homology 
searches were performed to 
establish orthologues of the 
all Plasmodium chan-
nels/pores (TCDB Class 
1.A/B [19]; pink), pumps 
(3.A; purple), porters (2.A; 
cyan), and unclassified, 
putative MTPs (yellow) in 
representative species of 
the entire breadth of the 
eukaryotic domain. Dot 
sizes indicate the fraction of 
the sequence length over 
which homology was de-
tected; red dots indicate 
reciprocal orthologues. 
When a protein has not 
been given a name, these 
are indicated by their P. 
falciparum geneID number. 
MTPs for which the encod-
ing genes were deleted 
successfully are indicated in 
blue, unsuccessful gene 
deletions suggesting essen-
tial functions during blood-
stage development are 
highlighted in red. (®, spe-
cies harbouring plastids of 
red algal origin; *, putative 
heavy metal transporting 
MTPs) Please see the con-
tinuation of the table on the 
next page. 
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that humans harbour fourteen zinc-iron permeases [37], 
although only one of these bears any sequence similarity 
to the Plasmodium copies. Nevertheless, caution is needed 
to ensure that the compound is sufficiently parasite-
specific. Phylogenetic profiling of the identified ZIP se-
quences supports a relatively recent gene duplication at 
the root of the Aconoidasida (Figure 2), and the relatively 
long distance from the vertebrate ZIPs suggest that specific 
targeting of the Plasmodium ZIPs might be feasible. 
Other MTPs with roles during mouse/human-to-
mosquito host transition have been identified, such as the 
Ca
2+
/H
+
 exchanger (CAX) [38], a cation diffusion factor or 
putative zinc transporter (CDF) [23], and the pantothenate 
transporter [23,39]. Unfortunately, not a single MTP has 
been identified that is critical for both male and female 
gametocyte formation, although it remains to be tested if 
zip1
–
 female gametocytes remain fertile or have lost the 
capacity to reproduce. 
 
Potential therapeutic drug targets 
Two types of channels have been discussed as potential 
therapeutic drug targets. Two potassium channels (K1 and 
K2) were refractory to gene deletion in P. falciparum [40]. 
However, absence of supporting evidence that this was not 
merely due to the technical difficulties of targeting P. falci-
parum genes and the fact that PbK1 could be readily delet-
ed [41] suggest that these channels may not be strictly 
necessary for blood-stage survival. The suitability of 
aquaglyceroporin (AQP) has also been subject of contro-
versy. Initial studies demonstrated that blood-stage growth 
of aqp
–
 parasites was strongly affected [42]. Independently, 
we were only able to replicate a minor defect in Swiss-
Webster mice [43]. Using a sensitive flow cytometry - 
based method in NMRI mice, we saw no difference in 
growth rates of WT and aqp
–
 parasites either growing in 
direct competition or in individual mice [44]. The relevant 
difference between NMRI and Swiss-Webster mice that 
may lead to this observation is unclear. 
Interestingly, a vast majority of the currently identified 
resistance markers, e.g. the ABC family [11], as well as the 
single validated druggable MTP, ATP4 [16,17], are primary 
active transporters that require ATP to fuel their activity. 
As the parasite invests energy in their functioning, it is per-
haps not surprising that many pumps play crucial roles at 
some stages during the parasite’s life cycle. Indeed, of all 
nineteen targeted pumps, eleven were shown to be refrac-
tory to gene deletion (Table S1). In addition to the four 
MDRs (MDR1, MDR4, MDR6, and MDR7) [22], these in-
 
FIGURE 2: Phylogenetic tree iron-zinc permeases. ZIPCO and ZIP1 are two zinc-iron permeases, the first is important for mosquito-to-mouse 
transition, while the second is vital for male gametocyte formation and transmission to the malaria mosquito. This is a maximum likelihood 
tree of the orthologues found in a variety of eukaryotes, including humans. Nodes with support values <50 are left unresolved. The 
aconoidasidan paralogues ZIPCO and ZIP1 resolve with good support values, suggesting that the genes duplicated after differentiation of the 
Aconoidasida. 
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clude the putative cation transporting ATPase, ATP4, (S. 
Kenthirapalan, K. Matuschewski, T.W.A. Kooij, unpublished 
data), ATP6 [45] and the V-type proton ATPase subunit G 
[46], ABCI3, and four predicted aminophospholipid trans-
porters [23]. 
Our orthology profiling indicates that the ABC trans-
porters, with the exception of MDR1 (and to lesser extent 
MDR2), are poorly conserved across the eukaryotic king-
dom, further highlighting their potential as anti-malarial 
drug targets (Figure 1). ABCI3 appears to be a unique, 
Plasmodium-specific ABC family member and is character-
ized by the presence of two transmembrane domains con-
sisting of multiple transmembrane helices interspersed by 
a single nucleotide-binding domain. An extensive phyloge-
netic profiling of all ABC transporters identified in 16 eu-
karyotic and 55 prokaryotic genomes assigned PfABCI3 to a 
poorly supported clade together with sequences from two 
archaea from two different kingdoms and sequences from 
five bacteria from four different phyli [47]. Thus, the 
orthology and phylogeny of ABCI3, along with demonstrat-
ed essential function during blood-stage development, 
strengthen its potential as a therapeutic drug target. 
Another class of primary active transporters that was 
highlighted for its druggable potential consists of putative 
aminophospholipid-transporting P4-type ATPases, from 
hereon referred to as flippases [23]. In addition to ATP2, 
ATP7, and ATP8, these also include two putatively bifunc-
tional proteins that also harbour guanylyl cyclase (GC) ac-
tivity [48]. GCα, like the other flippases, was essential for 
blood-stage development, whereas GCβ plays a critical role 
in colonization of the mosquito midgut [23,49,50]. While 
parts of the GCs are conserved, no bifunctional 
 
 
 
FIGURE 3: Phylogenetic tree of putative flippases. Four of five Plasmodium berghei putative aminophospholipid-transporting P4-type 
ATPases were shown to be essential for blood-stage development in vivo. This is a maximum likelihood tree based on the complete se-
quences of the identified orthologues along with models of all the domain architectures. Nodes with support values <50 are left unresolved. 
This unrooted tree shows low resolution at the base, making it difficult to interpret their phylogenetic history despite the fact that the pro-
teins share their structures. ATP8 forms a well-supported clade with orthologues from a variety of species, while the apicomplexan branch-
es with poor orthology assignments (GCα, GCβ, and ATP7) resolve well supporting the candidacy of GCα and ATP7 as therapeutic drug tar-
gets. 
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orthologues were found outside the apicomplexan clade 
(Figure 1). The phylogenetic tree of the flippases confirmed 
this notion (Figure 3). Orthology and phylogenetic profiles 
further indicate that ATP2 and ATP8 are rather well con-
served including human orthologues, whereas ATP7 is 
largely apicomplexan-specific (Figure 1). Combined, these 
data suggest that ATP7 and GCα may form attractive tar-
gets for novel anti-malarial compounds. Of note, for one P. 
falciparum gene encoding a putative flippase 
(PF3D7_1468600), no orthologue exists in P. berghei and a 
possible essential role has not yet been established. 
Of the largest group of MTPs, the porters (TCDB Class 
2.A) [19], 28 genes have been targeted in P. berghei, only 
three times without success (Table S1). In addition to the 
well-studied CRT [51], these include a hexose transporter 
HT [52], which is well conserved including in humans (Fig-
ure 1), and the putative drug metabolite transporter DMT2 
[23]. The latter presents a particularly interesting case con-
sidering the orthology discovery. Orthologues were identi-
fied in all apicomplexan parasites, with the exception of 
Cryptosporidium, in other alveolates, but not ciliates, and 
in the cryptomonad, G. theta, and most stramenopiles. 
Most species have a single DMT2 but T. gondii, N. caninum, 
and V. brassicaformis have multiple copies. While the exact 
phylogenetic relationships of the alveolates, cryptomonads, 
and stramenopiles is still a topic of debate, many of these 
chromalveolates, as they are commonly referred to, har-
bour a plastid of red algal origin. Ciliates and Cryptosporid-
ium species do not have such a plastid and thus it is tempt-
ing to speculate that DMT2 localizes to this endosymbiotic 
organelle. Indeed, the red alga Cyanidioschizon merolae 
appears to harbour a sequence with a very weak similarity 
that was initially just below the cut-off E-value applied to 
establish significant homologies. However, the presence of 
a rather well conserved copy in P. infestans, that lacks a 
relic plastid, and presence of weak similarities in three 
other unrelated eukaryotes (Giardia lamblia, Dictyostelium 
discoideum, and Chlamydomonas reinhardtii) suggest that 
the evolutionary history of this gene may be more compli-
cated. When building a maximum likelihood tree for all 
identified homologues, including the few hits from unre-
lated species, the tree does not resolve well (data not 
shown). However, when only including sequences from the 
chromalveolates and the red alga, the tree is well-
supported showing phylum-specific clades with Cyanidi-
oschizon merolae as the outmost group of the tree (data 
not shown). Attempts to include other sequences as out-
group, e.g. Plasmodium DMT1 sequences, were unsuccess-
ful due to a lack in sequence similarity and the consequent-
ly poorly resolving sequence alignments. The most con-
sistent results were obtained when using a single DMT2 
homologue of one of the three unrelated species as an 
outgroup (Figure 4). 
Despite the significant uncertainties and remaining un-
resolved questions about the origin of DMT2, these data 
could well suggest that this essential MTP is localized in the 
parasite’s apicoplast. Our initial localization studies were 
hampered by very low expression levels of the protein and 
hence difficult to interpret, but appeared to indicate an 
intraparasitic staining including a specific, small structure 
that may well be the apicoplast [23]. In blood-stage para-
sites, the single critical role of the apicoplast was shown to 
be the production of isopentenyl pyrophosphate (IPP) [53] 
and it is tempting to speculate that DMT2 is the dedicated 
IPP transport protein. However, DMT2 may also be in-
volved in critical processes for the maintenance of the or-
ganelle and the IPP biosynthesis pathway, e.g. through the 
import of sulphur or iron into the organelle for essential 
iron-sulphur cluster biosynthesis [54]. 
 
 
FIGURE 4: Phylogenetic tree of drug metabolite transporter 2 (DMT2). Plasmodium berghei DMT2 was shown to be essential for blood-
stage development in vivo. This is a maximum likelihood tree of all homologues found in chromalveolate species and the red alga Cyanidi-
oschyzon merolae using the Giardia lamblia homologue as an outgroup. Nodes with support values <50 are left unresolved. Apicomplexan 
DMT2 sequences, including the different paralogous sequences, form a distinct and well-supported clade, while the red algal distant homo-
logue and the majority of other chromalveolates sequences sit unresolved at the base of this clade. 
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Conclusions 
In conclusion, our extensive orthology assignment and 
phylogenetic profiling, in combination with published ex-
perimental genetics studies, particularly in the murine ma-
laria model parasite P. berghei, support the candidacy of a 
number of prophylactic, therapeutic, and transmission-
blocking drug targets. Further studies into the biochemical 
and structural properties of these MTPs are required and 
deserve prioritization. 
 
MATERIALS AND METHODS 
Identification of putative orthologues 
We first selected candidate protein sequences by homology 
search using Blast (blastp, version 2.2.29+) [55], against a set 
of pre-selected proteomes (Table S2) applying a threshold for 
being considered significant of E=5e
-4
. Next, for each candi-
date, we performed a reciprocal Blast search against the 
Plasmodium falciparum genome. To circumvent incomplete 
annotations of the genomes, we have additionally searched 
each query against the NCBI non-redundant (NR) database 
from March 19th, 2016. Hits on the same sequence were ana-
lysed and the overall coverage of the identified homology was 
calculated as the fraction of the query length. Candidates 
which returned the same protein as the original query (i.e., 
reciprocal blast hits) were kept as putative orthologues, while 
remaining hits were retained as unspecified homologues. We 
further inspected the putative homologues using the RADS 
algorithm [56] and the Needleman-Wunsch global alignment 
algorithm. 
 
Phylogenetic reconstruction 
Groups of putative orthologues for selected proteins were 
aligned using the programme Clustal Omega v. 1.2.1 [57] with 
default parameters. The alignments were then manually in-
spected and regions of low coverage and poor conservation 
were masked. Maximum likelihood phylogeny reconstruction 
was performed with the TreePuzzle [58] with 10,000 iterations 
and a mixed model of rate homogeneity. 
 
Domain analysis 
Domains of protein sequences were detected with hmmscan 
from the HMMer package v. 3.1b1 (http://hmmer.org) and the 
HMM profile collection from the PfamA database (October 
2015). Significant overlaps were solved by E-value precedence. 
Domain architectures were analysed in combination with phy-
logenetic trees using the DoMosaic programme [59]. 
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